Brandon Capital (Brandon BioCatalyst / MRCF)

Investment thesis

Manager of Brandon BioCatalyst (formerly the Medical Research Commercialisation Fund, established 2007), Australia and New Zealand's largest life science investment collaboration. A partnership between superannuation funds, Australian and New Zealand governments, state governments and 50+ medical research institutes and hospitals, investing in new therapeutics, devices and diagnostics; funds under management exceed A$800m.

Sector focus